Changes in mortality associated with cancer drug approvals in the United States from 2000 to 2016

Multiple factors have contributed to recent reductions in cancer mortality, including declines in smoking rates, treatment advances and better screening. But a key question remains: how much have recent developments in oncology treatments contributed to the decline of cancer mortality in the USA?

In a new study, PRECISIONheor experts found new cancer treatments accounted for a 24% decline in US cancer deaths from the 15 most common tumor types combined from 2000 to 2016..

Read the full article here!